According to an October 10 press release, a World Health Organization (WHO) report found that vaccines against 24 pathogens could reduce the number of antibiotics needed each year worldwide by 22%, or 2.5 billion doses per day. It has been found that doses can be reduced in defined doses, supporting global efforts to address this problem. Antimicrobial resistance (AMR). Some of these vaccines are already available but underutilized, while others need to be developed and brought to market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites become unresponsive to antibiotics, making people sicker and increasing the risk of illness, death, and the spread of difficult-to-treat infections. AMR is primarily caused by the misuse and overuse of antibiotics, but at the same time, many people around the world do not have access to essential antibiotics. There are nearly 5 million AMR-related deaths worldwide each year. Vaccines are an important part of measures to reduce AMR because they prevent infectious diseases, reduce the use and overuse of antibiotics, and slow the emergence and spread of drug-resistant pathogens. The new report expands on WHO research published last year in BMJ Global Health. The report found that vaccines already in use against pneumococcus, Haemophilus influenzae type B (Hib, the bacterium that causes pneumonia and meningitis), and typhoid fever account for up to 106,000 AMR-related deaths annually. It is estimated that it is possible to avoid this. An additional 543,000 AMR-related deaths per year could be avoided if new vaccines against tuberculosis (TB) and Klebsiella pneumoniae are developed and rolled out worldwide. New tuberculosis vaccines are in clinical trials, while vaccines against Klebsiella pneumoniae are in the early stages of development.
